{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:23:11Z","timestamp":1782519791958,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jcv.2026.105926","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:58:15Z","timestamp":1771261095000},"page":"105926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Seroprevalence of Respiratory Syncytial Virus in the antenatal population in British Columbia: A cross-sectional study"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3899-5205","authenticated-orcid":false,"given":"Saina","family":"Beitari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Citlali","family":"M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Valadbeigy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha","family":"Jassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"McClymont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Money","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Sekirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2026.105926_bib1","unstructured":"World Health Organization. Respiratory Syncytial Virus (RSV) [Internet]. 2025 [cited 2025 Mar 5]. Available from: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/respiratory-syncytial-virus-(rsv)#:\u223c:text=Each%20year%20RSV%20causes%20over,access%20to%20supportive%20medical%20care\u3009."},{"issue":"10","key":"10.1016\/j.jcv.2026.105926_bib2","doi-asserted-by":"crossref","first-page":"e1247","DOI":"10.1016\/S2214-109X(20)30303-X","article-title":"RSV lower respiratory tract infection and lung health in the first 2 years of life","volume":"8","author":"Verwey","year":"2020","journal-title":"Lancet Glob. Health"},{"issue":"10340","key":"10.1016\/j.jcv.2026.105926_bib3","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to Respiratory Syncytial Virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jcv.2026.105926_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.16852","article-title":"Pediatric Respiratory Syncytial Virus hospitalizations and respiratory support after the COVID-19 pandemic","volume":"7","author":"Winthrop","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.jcv.2026.105926_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/QCO.0000000000000952","article-title":"The disease burden of Respiratory Syncytial Virus in Infants","volume":"36","author":"Munro","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.jcv.2026.105926_bib6","doi-asserted-by":"crossref","first-page":"e4384","DOI":"10.1093\/cid\/ciaa1612","article-title":"Respiratory Syncytial Virus disease severity in young children","volume":"73","author":"Haddadin","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2026.105926_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coi.2015.04.005","article-title":"Novel antigens for RSV vaccines","volume":"35","author":"Graham","year":"2015","journal-title":"Curr. Opin. Immunol."},{"issue":"535","key":"10.1016\/j.jcv.2026.105926_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2466","article-title":"Priorities for developing Respiratory Syncytial Virus vaccines in different target populations","volume":"12","author":"Drysdale","year":"2020","journal-title":"Sci. Transl. Med"},{"issue":"14","key":"10.1016\/j.jcv.2026.105926_bib9","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1128\/JVI.74.14.6442-6447.2000","article-title":"The fusion glycoprotein of human Respiratory Syncytial Virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate","volume":"74","author":"Feldman","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2026.105926_bib10","article-title":"The recent landscape of RSV vaccine research","volume":"13","author":"Kelleher","year":"2025","journal-title":"Ther. Adv. Vaccin. Immunother."},{"issue":"2","key":"10.1016\/j.jcv.2026.105926_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/vaccines13020097","article-title":"Development, current status, and remaining challenges for Respiratory Syncytial Virus vaccines","volume":"13","author":"Anastassopoulou","year":"2025","journal-title":"Vaccines"},{"issue":"16","key":"10.1016\/j.jcv.2026.105926_bib12","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jcv.2026.105926_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/pathogens13030200","article-title":"Prenatal maternal immunization for infant protection: a review of the vaccines recommended, infant immunity and future research directions","volume":"13","author":"Quincer","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.jcv.2026.105926_bib14","series-title":"Summary of NACI statement of July 12, 2024: Statement on the prevention of Respiratory Syncytial Virus disease in older adults","author":"National Advisory Committee on Immunization (NACI): Statements and publications","year":"2024"},{"issue":"4","key":"10.1016\/j.jcv.2026.105926_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106466","article-title":"Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024","volume":"90","author":"Wadia","year":"2025","journal-title":"J. Infect."},{"key":"10.1016\/j.jcv.2026.105926_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/apa.70066","article-title":"Nirsevimab immunisation significantly reduces Respiratory Syncytial Virus-associated bronchiolitis hospitalisations and alters seasonal patterns","author":"Rius-Peris","year":"2025","journal-title":"Acta Paediatr."},{"issue":"5","key":"10.1016\/j.jcv.2026.105926_bib17","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-067174","article-title":"RSV neutralizing antibodies following nirsevimab and palivizumab dosing","volume":"154","author":"Wilkins","year":"2024","journal-title":"Pediatrics"},{"issue":"23","key":"10.1016\/j.jcv.2026.105926_bib18","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.vaccine.2017.04.053","article-title":"A multi-laboratory study of diverse RSV neutralization assays indicates feasibility for harmonization with an international standard","volume":"35","author":"Hosken","year":"2017","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.jcv.2026.105926_bib19","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1016\/j.vaccine.2021.06.016","article-title":"RSV neutralization assays \u2013 use in immune response assessment","volume":"39","author":"Raghunandan","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2026.105926_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.105050","article-title":"A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG","volume":"146","author":"Li","year":"2022","journal-title":"J. Clin. Virol."},{"issue":"1","key":"10.1016\/j.jcv.2026.105926_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01454-21","article-title":"Evaluation of the performance of a multiplexed serological assay in the detection of SARS-CoV-2 infections in a predominantly vaccinated population","volume":"10","author":"Asamoah-Boaheng","year":"2022","journal-title":"Microbiol Spectr."},{"issue":"26","key":"10.1016\/j.jcv.2026.105926_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126453","article-title":"Evaluation of a multiplexed immunoassay for assessing long-term humoral immunity orthopoxviruses","volume":"42","author":"Hicks","year":"2024","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jcv.2026.105926_bib23","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.9778\/cmajo.20220045","article-title":"Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study","volume":"11","author":"Atkinson","year":"2023","journal-title":"CMAJ Open"},{"issue":"11","key":"10.1016\/j.jcv.2026.105926_bib24","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jogc.2021.06.001","article-title":"Population SARS-CoV-2 seroprevalence using antenatal serum samples in British Columbia, Canada","volume":"43","author":"McClymont","year":"2021","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"9","key":"10.1016\/j.jcv.2026.105926_bib25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.cmi.2024.06.005","article-title":"Antibody responses to Respiratory Syncytial Virus: a population-based cross-sectional serological study in Southern China, 2021","volume":"30","author":"Wang","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.jcv.2026.105926_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/infdis\/jiaa483","article-title":"Antibody responses to Respiratory Syncytial Virus: a cross-sectional serosurveillance study in the Dutch population focusing on infants younger than 2 years","volume":"224","author":"Berbers","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2026.105926_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2024.06.005","article-title":"Antibody responses to Respiratory Syncytial Virus: a population-based cross-sectional serological study in Southern China, 2021","author":"Wang","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.jcv.2026.105926_bib28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/vaccines12050513","article-title":"Age-stratified seroprevalence of Respiratory Syncytial Virus: analysis using prefusion F and G protein antibodies","volume":"12","author":"Nham","year":"2024","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.jcv.2026.105926_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177803","article-title":"Defining the vaccination window for Respiratory Syncytial Virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya","volume":"12","author":"Nyiro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2026.105926_bib30","article-title":"Respiratory Syncytial Virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada: a retrospective observational study","volume":"25","author":"Vi\u00f1eta Paramo","year":"2023","journal-title":"Lancet Reg. Health Am."},{"issue":"1","key":"10.1016\/j.jcv.2026.105926_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae723","article-title":"Maternal-infant Respiratory Syncytial Virus and influenza A virus antibody transfer in preterm and full-term infants","volume":"12","author":"Rumfelt","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.jcv.2026.105926_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcv.2017.08.017","article-title":"Transplacental transfer of maternal Respiratory Syncytial Virus (RSV) antibody and protection against RSV disease in infants in rural Nepal","volume":"95","author":"Chu","year":"2017","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2026.105926_bib33","doi-asserted-by":"crossref","first-page":"1620S","DOI":"10.3945\/ajcn.117.155903","article-title":"Emerging understanding and measurement of plasma volume expansion in pregnancy","volume":"106","author":"Vricella","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.jcv.2026.105926_bib34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12884-019-2619-6","article-title":"Plasma volume expansion across healthy pregnancy: a systematic review and meta-analysis of longitudinal studies","volume":"19","author":"Aguree","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"issue":"12","key":"10.1016\/j.jcv.2026.105926_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02115-24","article-title":"Clinical validation of an RSV neutralization assay and analysis of cross-sectional sera associated with 2021\u20132023 RSV outbreaks to investigate the immunity debt hypothesis","volume":"12","author":"Piliper","year":"2024","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.jcv.2026.105926_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102089","article-title":"Why has the epidemiology of RSV changed during the COVID-19 pandemic?","volume":"61","author":"Abu-Raya","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.jcv.2026.105926_bib37","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-063667","article-title":"Clinical, genomic, and immunological characterization of RSV Surge in Sydney, Australia, 2022","volume":"153","author":"Walker","year":"2024","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jcv.2026.105926_bib38","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1093\/infdis\/jiaf101","article-title":"Recovery of antibody immunity after a resurgence of Respiratory Syncytial Virus infections","volume":"231","author":"Reicherz","year":"2025","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2026.105926_bib39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s15010-024-02180-6","article-title":"Development and validation of a Respiratory Syncytial Virus multiplex immunoassay","volume":"52","author":"Marsall","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.jcv.2026.105926_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126936","article-title":"Binding and neutralising antibodies to Respiratory Syncytial Virus and influenza A virus in serum and bronchoalveolar lavage fluid of healthy adults in the United States: a cross-sectional study","volume":"53","author":"Raja","year":"2025","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jcv.2026.105926_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153019","article-title":"Development of electrochemiluminescent serology assays to measure the humoral response to antigens of respiratory syncytial virus","volume":"11","author":"Maifeld","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jcv.2026.105926_bib42","doi-asserted-by":"crossref","first-page":"e1138","DOI":"10.1093\/infdis\/jiaf168","article-title":"Strength and durability of Respiratory Syncytial Virus prefusion F immunoglobulin G following infection and exposure in a household cohort, 2014\u20132022","volume":"231","author":"Rumfelt","year":"2025","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.jcv.2026.105926_bib43","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jogc.2021.06.001","article-title":"Population SARS-CoV-2 seroprevalence using antenatal serum samples in British Columbia, Canada","volume":"43","author":"McClymont","year":"2021","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"1","key":"10.1016\/j.jcv.2026.105926_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12884-024-07070-1","article-title":"Understanding the experiences of young, urban, indigenous mothers-to-be in British Columbia, Canada","volume":"25","author":"Catherine","year":"2025","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653226000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653226000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:02:45Z","timestamp":1775102565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653226000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"alternative-id":["S1386653226000156"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2026.105926","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of Respiratory Syncytial Virus in the antenatal population in British Columbia: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2026.105926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105926"}}